Blake Wise is the founder of Novome Biotechnologies. Novome Biotechnologies has raised $33M in total funding. Latest round: Series A.
Blake Wise was appointed Chief Executive Officer of Novome Biotechnologies in January 2020. Prior to joining Novome, he served as CEO of Achaogen, a biopharmaceutical company, and held leadership positions at Genentech. He oversees the development of Novome's Genetically Engineered Microbial Medicines (GEMMs) platform for treating chronic diseases.
Full founder directory · Investor directory · Company funding database · Fundraising library